ISB Adopts Kreatech's ULS™ Nucleic Acid Labeling Technology
News Sep 22, 2005
The continuing scientific collaboration between the Institute of Systems Biology and Kreatech's product development team has resulted in an arrangement between Kreatech and the ISB for the use of Kreatech's commercial products.
Kreatech's platinum based "Universal Linkage System" (ULS™), a non-enzymatic way of labeling nucleic acids with detectable molecules such as fluorophores, has been adopted by Dr. Nitin Baliga's research group and is now the preferred labeling method for both bacterial gene expression profiling and Chip on Chip assays that have been developed at the ISB.
Currently available kits from Kreatech are optimized for labeling of amplified RNA for gene-expression analysis and for labeling of genomic DNA for microarray based comparative genomic hybridization (arrayCGH).
This collaboration with the ISB will help Kreatech to position the ULS technology in new application areas.
"We are pleased and very proud with the fact that a renowned institute like the Institute of Systems Biology has made the switch to our technology", says Alexander Altink, Kreatech's CEO.
The labeling kits used by the ISB include the purification columns (KREApure), blocking buffer (KREAblock) and ULS bound with Dyomics' DY Dyes.
"We have been working with this technology for a while and we like both the reproducible labeling efficiencies as well as the one-step purification of labeled material", says Dr. Nitin Baliga, Assistant Professor at the ISB.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE